Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation

Among patients with heart failure with moderate to severe functional mitral regurgitation who received medical therapy, the addition of transcatheter mitral-valve repair led to a lower rate of first or recurrent hospitalization for heart failure or cardiovascular death and a lower rate of first or recurrent hospitalization for heart failure at 24 months and better health status at 12 months than medical therapy alone. (Funded by Abbott Laboratories; RESHAPE-HF2 ClinicalTrials.gov number, NCT02444338.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2024-08-31
DOI
https://doi.org/10.1056/nejmoa2314328
Citations
201
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
80.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation

Efstratios K. Theofilogiannakos, Gerd Hasenfuß, Malte Kelm, Mark C. Petrie et al.
201 citations
New England Journal of Medicine
Cardiac Valve Diseases and Treatments
80.81
article

Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation

Efstratios K. Theofilogiannakos, Gerd Hasenfuß, Malte Kelm, Mark C. Petrie, Finn Gustafsson, Karl‐Heinz Kück, Frank Thomas Ruschitzka, Marius Placzek, Michael Chrissoheris, Antoni Bayés‐Genís, Fausto José Pinto, John G.F. Cleland, Piotr Ponikowski, Evelyn Santiago‐Vacas, Javed Butler, Gerasimos S Filippatos, Wojciech Wojakowski, Vlasis N. Ninios, Martin Geyer, Łukasz Wiewiórka, Grzegorz Smołka, Jutta Heinrich, Ulf Landmesser, Konstantinos Spargias, Marco Metra, Stefan D. Anker, Ralph-Stephan von Bardeleben, Tim Friede, Mitja Lainščak, Alec Vahanian, Tienush Rassaf, Andreas M. Zeiher, Panagiota Kourkoveli, William T. Abraham, Angelo Auricchio, Monika Diek, Marianna Adamo, Zbigniew F. Kalarus, Ottavio Alfieri, Krzysztof Reczuch, Wilhelm Haverkamp, Friedrich Koehler, Aldo P. Maggioni, T. Ruf, Ilias Ninios, Jose Luis Zamorano, Roberto Ferrari, Κωνσταντίνος Παπαδόπουλος, Alper Öner, Ulrich Schäfer, M. Gross, P. Christian Schulze, Wolfgang Schillinger, Joern Tongers, Mahir Karakas, M M Khan, Nikolaos Mezilis
article en
201 citations

Abstract

Among patients with heart failure with moderate to severe functional mitral regurgitation who received medical therapy, the addition of transcatheter mitral-valve repair led to a lower rate of first or recurrent hospitalization for heart failure or cardiovascular death and a lower rate of first or recurrent hospitalization for heart failure at 24 months and better health status at 12 months than medical therapy alone. (Funded by Abbott Laboratories; RESHAPE-HF2 ClinicalTrials.gov number, NCT02444338.).

New England Journal of MedicineVol. 391(19)
Deutsches Herzzentrum der Charité (DE), German Centre for Cardiovascular Research (DE)
Good health and well-being
Openalex Percentile: Top 0%
Cardiac Valve Diseases and Treatments
80.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.